Suggestions
Yury Oreshin
--
Yury Oreshin is a business professional with a background in venture capital, investment, and biotechnology. Based on the available information:
Professional Background
Yury Oreshin currently holds the position of Investor at INARCTICA, a company based in Moscow, Russia.1 His professional experience includes:
- Managing Partner and Founder of Angelico Ventures2
- CEO at Aiternis, a company focused on anti-aging science and medicine2
- General Director at SL Oncology, a Russian subsidiary of CureLab Oncology, since 20122
- Director of Licensing and Business Development at Human Stem Cells Institute (HSCI) from 2012 to 20152
- Advisor for Edalau, focusing on cross-border transactions between London, Paris, Moscow, and Kiev, prior to 20082
Education
Yury holds a Bachelor of Science in Business Administration (BSBA) with a focus on International Business and Marketing from the University of South Carolina - The Moore School of Business, which he obtained between 2002 and 2005.1
Skills and Expertise
His skill set includes:
- Venture Capital
- Mergers
- Investment Banking
- Biotechnology
- Life Sciences1
Additional Information
Yury Oreshin has been involved in various biotechnology and investment ventures. He is a co-founder of Alvansa (Alium) and an investor in CureLab Oncology.2 His work at Aiternis involved recruiting a team of world leaders in anti-aging science, medicine, healthcare, IT, and business management.2
It's worth noting that while this information provides an overview of Yury Oreshin's professional background, the specific details of his current role and activities may have changed since the last available update.
